Read + Share
Amedeo Smart
Independent Medical Education
Wang M, Huang H, Xu Z, Li Z, et al. Proposal for multiple new lesions as complement of hyperprogressive disease in NSCLC patients treated with PD-1/PD-L1 immunotherapy. Lung Cancer 2022;173:28-34.PMID: 36116167
Email
LinkedIn
Facebook
Twitter
Privacy Policy